Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Comparison of ATPIII and IDF classifications Kaplan Meier survival.

Slides:

Advertisements

Similar presentations

Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?

Advertisements

Simvastatin in Patients With Prior Cerebrovascular Disease: HPS

1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.

COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)

Diabetes National Diabetes Control Programme

Shalev V, et al. Arch Intern Med 2009; 169:

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mortality and Cardiovascular Events Are Best Predicted.

Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.

Cardiovascular Risk: A global perspective

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nonfasting Glucose, Ischemic Heart Disease, and.

ADULT GROWTH HORMONE DEFICIENCY

Dr John Cox Diabetes in Primary Care Conference Cork

The SPRINT Research Group

Pathophysiology and Prevention of Heart Disease in Diabetes Mellitus

Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:

“The Bulgarians stand at the basis of human civilization

Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;

Clinical need for determination of vulnerable plaques

Copyright © 2007 American Medical Association. All rights reserved.

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Copyright © 2009 American Medical Association. All rights reserved.

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Systolic Blood Pressure Intervention Trial (SPRINT)

The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry by Hemant Kulkarni, Vincent C. Marconi,

Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.

A: Epidemiology update

Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Arjun Pennathur, MD, Liqiang Xi, MD, Virginia R. Litle, MD, William E

Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis Jana Ortmann, MD, Eveline Nüesch, PhD,

Diabetes Journal Club March 17, 2011

Impact of metabolic risk factors on HCC

ASPIRE CLASS 6: Interpreting Results and Writing an Abstract

Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency Jana Ortmann, MD, Brigitta Gahl, MD, Nicolas Diehm,

Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian, Yan Yan, Ziyad Al-Aly

Svend A. Mortensen et al. JCHF 2014;2:

Enrollment and Outcomes

Cumulative incidences of events, according to glucose-control strategy

Baseline Characteristics of the Subjects

Baseline Characteristics According to Sex

Characteristics of Study Subjects and Events, According to the Quintile of Exposure to Fine Particulate Matter (PM2.5)* - Part I Kristin A. Miller et al.

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Baseline Characteristics of the Subjects*

Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:

A Kaplan-Meier curve showing the cumulative incidence of the secondary NFE of TLR or de novo PCI during the 5-year follow-up (30 patients) (A) A heat map.

Kaplan-Meier survival curves for the development of diabetes by quartiles of baseline pedometer steps. Kaplan-Meier survival curves for the development.

Kaplan-Meier curves showing the time in months to the first inappropriate shock from the start of remote monitoring in primary and secondary prevention.

Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus James H. O'Keefe, MD, Mohammad Abuannadi,

Carotid endarterectomy with a polyurethane patch versus primary closure: A prospective randomized study Dallit Mannheim, MD, Boaz Weller, MD, Eran Vahadim,

Simvastatin in Patients With Prior Cerebrovascular Disease: HPS

Volume 75, Issue 1, Pages (January 2009)

Comparison of Baseline Characteristics by Primary End Point

Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients Kim et al. Am J Nephrol 2016;44:71-80.

Prevalence of diabetes (DM) after pancreaticoduodenectomy for PDAC

A: Relative risk of experiencing one or more hypoglycemic events per participant at any time (24 h) and during the night (0000–0559 h) for Gla-300 vs.

Associations between type of MI and incident HF

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

The benefit of evolocumab treatment is consistent regardless of inflammation level HR %CI ARR 1.6% 1.8%

The Kaplan-Meier curves display the time to event for the primary outcome (A) and total mortality (B) during follow-up from randomization until the end.

Kaplan-Meier curves for the end point all-cause mortality in the total patient population stratified according to complete/incomplete revascularisation.

A: Incidences of all-cause mortality, coronary artery events, and cerebrovascular events by quartiles of baPWV during the follow-up period. A: Incidences.

Frankel DS, et al. J Am Coll Cardiol. 2009;53:754-62

Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.

The ROC curves analyzing the sensitivity and specificity of rCBVmax values in astrocytomas for 1-year survival (A) and recurrence (B) show the optimal.

Daniele Muser et al. JACEP 2017;j.jacep

Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.

Cumulative mean numbers of confirmed (plasma glucose ≤3

Presentation transcript:

Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Comparison of ATPIII and IDF classifications Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Comparison of ATPIII and IDF classifications. The label on the right side of each line represents the corresponding MS status, “ATPIII” stands for MS classified according to the Adult Treatment Panel III. “IDF” stands for MS classified using the International Diabetes Federation. In the second row of the label, number of events/number of subjects in the group. X-axis = years of follow-up. Y-axis = proportion of subjects free of CV events. Inside panel = hazard ratios of MS groups vs. the respective non-MS groups by the Cox model (age and gender adjusted) and 95th confidence intervals in brackets. Noto D, et al. Atherosclerosis 2008;197:147-53

Clinical and biochemical parameters in the study population Noto D, et al. Atherosclerosis 2008;197:147-53

Prevalence of cardiovascular risk factors in the study population Noto D, et al. Atherosclerosis 2008;197:147-53

15 years cumulative incidences and hazard ratios for CV events in metabolic syndromea (primary and secondary endpoints) Noto D, et al. Atherosclerosis 2008;197:147-53

Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Survival according to Metabolic Syndrome and impaired fasting blood glucose/diabetes mellitus Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Survival according to Metabolic Syndrome and impaired fasting blood glucose/diabetes mellitus. The label on the right side of each line represents the corresponding MS/FBG status, “IFG” stands for Fasting Blood glucose ≥110 mg/dL (6.11 mmol/L) or Diabetes Mellitus. In the second row of the label, number of events/number of subjects in the group. X-axis = years of follow-up. Y-axis = proportion of subjects free of CV events. Inside panel = hazard ratios of MS groups vs. non-MS group by the Cox model (age and gender adjusted) and 95th confidence intervals in brackets. No survival is shown for the “no MS/IFG” group since few events/cases (7/34) were recorded in this group. No significant differences in the estimated survival probabilities were found between the MS subjects with/without IFG by the Cox model. Noto D, et al. Atherosclerosis 2008;197:147-53